APOE and Alzheimer disease: Recently, increased TREM2 mRNA levels in peripheral blood mononuclear cells (PBMCs) have been found to characterize AD patients compared to controls, and to be dependent on the APOE genotype, in accordance with data obtained using transgenic AD mouse models [72,73,74].